ChartMill assigns a Buy % Consensus number of 43% to EVOK. The Buy consensus is the weighted average rating of the current analysts ratings.
6 analysts have analysed EVOK and the average price target is 18.36 USD. This implies a price increase of 66.91% is expected in the next year compared to the current price of 11.
The consensus rating for EVOKE PHARMA INC (EVOK) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering EVOKE PHARMA INC (EVOK) is 6.